Dupuytren Research Group Inc
Data sourced from IRS 990 public filings
Dupuytren Research Group Inc Our Mission is to do whatever is needed to develop and test preventive treatments for Dupuytren disease and related conditions. Our core effort focuses on answering the greatest need in Dupuytren treatment: developing a Dupuytren blood test.
Annual Revenue
$174,941
Known Funders
11
Grants Received
17
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $261,908 | $166,423 | $719,801 |
| 2022 | $219,098 | $187,358 | $625,020 |
| 2021 | $197,762 | $225,604 | $595,262 |
| 2020 | $174,941 | $270,745 | $624,946 |
| 2019 | $399,852 | $142,918 | $717,384 |
| 2018 | $197,863 | $120,489 | $391,131 |
| 2017 | $222,006 | $108,760 | $319,734 |
| 2016 | $220,164 | $115,992 | $235,888 |
Top Funders
WORCESTER, MA
WELLESLEY, MA
WELLESLEY, MA
WELLESLEY, MA
LAS VEGAS, NV
SLEEPY HOLLOW, NY
Wilmington, DE
Wilmington, DE
Wilmington, DE
Wilmington, DE
Showing top 10 of 11 funders.
Key Personnel
From 2023 IRS 990 filing
DR Charles Eaton
Executive Director
Tom Hardart
Director
Keither Raskin MD
Director
Stuart Landow
Director
Laura Holmes Jost
Director
Gary Pess MD
Director
Peter Geimer
Director
Frequently Asked Questions
Other Nonprofits in Florida
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.